<DOC>
	<DOCNO>NCT02251704</DOCNO>
	<brief_summary>This epidemiology study plan run parallel EPI-MAL-002 EPI-MAL-003 study , enrol HDSS ( health demographic surveillance system ) population . The primary objective produce longitudinal estimate parasite prevalence human , record malaria control measure usage area EPI-MAL-002 EPI-MAL-003 study take place .</brief_summary>
	<brief_title>An Epidemiology Study Malaria Transmission Intensity Children Sub-Saharan Africa</brief_title>
	<detailed_description>Up 5 annual cross sectional survey peak transmission provide point estimate parasite prevalence subsequently longitudinal assessment level endemicity area cover EPI-MAL-002 EPI-MAL-003 . This study conduct parallel EPI-MAL-002 EPI-MAL-003 order ass parasite prevalence malaria control measure ( EPI-MAL-002 ) ( EPI-MAL-003 ) vaccine introduction . By take account variation MTI ( malaria transmission intensity ) malaria control intervention coverage , possible estimate accurately vaccine impact clinical disease EPI-MAL-003 .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>Subjects ' whose parent ( ) /Legally Acceptable Representative ( ) [ LAR ( ) ] , opinion investigator , comply requirement protocol . A male female 6 month &lt; 10 year age time survey . Signed informed consent thumbprinted witness informed consent obtain parent ( ) /LAR ( ) child . Child care . Current active participation trial involve administration investigational malaria vaccine malaria drug .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Malaria</keyword>
	<keyword>MTI</keyword>
	<keyword>Surveillance study</keyword>
	<keyword>Africa</keyword>
	<keyword>RTSS , adjuvant</keyword>
	<keyword>Epidemiology</keyword>
</DOC>